These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5635231)

  • 1. Some unusual experiences with oestrin therapy.
    Jowett RE
    J Laryngol Otol; 1968 Jan; 82(1):69-71. PubMed ID: 5635231
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of estrogen in treatment of familial hemorrhagic telangiectasia.
    Harrison DF
    Laryngoscope; 1982 Mar; 92(3):314-20. PubMed ID: 7040867
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of nose bleeds in hereditary haemorrhagic telangiectasia.
    Dunshea MG
    N Z Med J; 1970 Jan; 71(452):23-6. PubMed ID: 5265867
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemorrhagic telangiectasia.
    Ananthasubramaniam G; Sathyavathi R; Chitra N
    J Assoc Physicians India; 1981 May; 29(5):425-7. PubMed ID: 7298565
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Olitsky SE
    Am J Otolaryngol; 2012; 33(3):375-6. PubMed ID: 22079094
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives?
    Rowley PT; Kurnick J; Cheville R
    Lancet; 1970 Feb; 1(7644):474-5. PubMed ID: 4189787
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Sabbà C; Gallitelli M; Palasciano G
    N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
    Klepfish A; Berrebi A; Schattner A
    Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.
    Contis A; Gensous N; Viallard JF; Goizet C; Léauté-Labrèze C; Duffau P
    Clin Otolaryngol; 2017 Aug; 42(4):911-917. PubMed ID: 28032956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia].
    Xu C; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Saba HI; Morelli GA; Logrono LA
    N Engl J Med; 1994 Jun; 330(25):1789-90. PubMed ID: 8190155
    [No Abstract]   [Full Text] [Related]  

  • 12. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid in hereditary hemorrhagic telangiectasia.
    Lozano M
    N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In reference to hereditary hemorrhagic telangiectasia/avastin.
    Bachmann-Harildstad G
    Laryngoscope; 2010 Oct; 120(10):2134. PubMed ID: 20824638
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.
    Proctor DD; Henderson KJ; Dziura JD; White RI
    J Clin Gastroenterol; 2008 Jul; 42(6):756-7. PubMed ID: 18496387
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
    Minami K; Haji T
    Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.